Renhe Pharmacy Co.,Ltd (SHE:000650)
China · Delayed Price · Currency is CNY 5.70
-0.02 (-0.35%)
Apr 29, 2026, 3:04 PM CST
Renhe Pharmacy Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 463.72 | 487.66 | 481.91 | 567.26 | 574.43 | 665.02 |
Depreciation & Amortization | 115.85 | 115.85 | 121.82 | 141.7 | 117.15 | 86.64 |
Other Amortization | 3.37 | 3.37 | 3.68 | 5.45 | 6.58 | 5.5 |
Loss (Gain) From Sale of Assets | -2.05 | -2.05 | -1.37 | 0.27 | -0.34 | -16.84 |
Asset Writedown & Restructuring Costs | 104.47 | 104.47 | 105.01 | 207.63 | 32.42 | 1.44 |
Loss (Gain) From Sale of Investments | -83.43 | -83.43 | -88.74 | -76.09 | -68.43 | -31.45 |
Provision & Write-off of Bad Debts | - | - | 28.61 | 3.92 | 6.67 | 2.42 |
Other Operating Activities | 62.83 | 32.63 | 93.21 | 80.17 | 173.97 | 140.89 |
Change in Accounts Receivable | 178.96 | 178.96 | 149.68 | -118.15 | 127.1 | -62.47 |
Change in Inventory | -49.23 | -49.23 | 7.71 | 9.78 | 111.63 | -124.42 |
Change in Accounts Payable | 78.31 | 78.31 | -353.64 | -313.28 | 182.28 | 101.35 |
Change in Other Net Operating Assets | -15.53 | -15.53 | 15.53 | - | 17.32 | 10.39 |
Operating Cash Flow | 857.58 | 851.31 | 557.26 | 499.47 | 1,270 | 777.72 |
Operating Cash Flow Growth | 52.37% | 52.77% | 11.57% | -60.67% | 63.30% | -12.30% |
Capital Expenditures | -61.02 | -74.59 | -285.72 | -186.55 | -221.09 | -499.78 |
Sale of Property, Plant & Equipment | 0.35 | 0.36 | 8.95 | 2.02 | 0.29 | 22.63 |
Cash Acquisitions | -0.06 | -0.06 | - | - | - | -704.65 |
Divestitures | - | - | - | - | 15.78 | - |
Investment in Securities | -103.85 | -138.41 | -268.3 | -187.49 | -413.66 | 1,472 |
Other Investing Activities | 107.63 | 114.41 | 82.63 | 77.97 | 43.52 | 28.93 |
Investing Cash Flow | -56.96 | -98.29 | -462.44 | -294.04 | -575.17 | 319.26 |
Short-Term Debt Repaid | - | - | - | - | - | -60 |
Long-Term Debt Repaid | - | - | -5.89 | -7.07 | -5.55 | -3.55 |
Total Debt Repaid | - | - | -5.89 | -7.07 | -5.55 | -63.55 |
Net Debt Issued (Repaid) | - | - | -5.89 | -7.07 | -5.55 | -63.55 |
Issuance of Common Stock | - | - | - | - | - | 139.75 |
Repurchase of Common Stock | - | - | -39.93 | -60.08 | - | -199.64 |
Common Dividends Paid | -210.48 | -210.48 | -279.93 | -279.42 | -140.17 | -283.22 |
Other Financing Activities | -91.98 | -94.14 | -58.03 | -69.49 | -84.36 | -55.53 |
Financing Cash Flow | -302.46 | -304.62 | -383.78 | -416.06 | -230.08 | -462.19 |
Foreign Exchange Rate Adjustments | -0.03 | -0.01 | - | - | -0 | -0 |
Net Cash Flow | 498.13 | 448.4 | -288.96 | -210.63 | 464.74 | 634.79 |
Free Cash Flow | 796.56 | 776.72 | 271.54 | 312.92 | 1,049 | 277.93 |
Free Cash Flow Growth | 149.01% | 186.04% | -13.22% | -70.17% | 277.39% | -58.25% |
Free Cash Flow Margin | 21.65% | 21.96% | 6.66% | 6.22% | 20.35% | 5.63% |
Free Cash Flow Per Share | 0.57 | 0.55 | 0.20 | 0.22 | 0.75 | 0.20 |
Cash Income Tax Paid | 329.67 | 354.24 | 642.78 | 640.21 | 520.63 | 359.93 |
Levered Free Cash Flow | 676.43 | 630.1 | 125.8 | 136.97 | 892.17 | 211.09 |
Unlevered Free Cash Flow | 676.43 | 630.1 | 125.9 | 137.18 | 892.43 | 211.7 |
Change in Working Capital | 192.81 | 192.81 | -186.88 | -430.84 | 427.52 | -75.91 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.